Researchers from Harvard and Brigham and Women’s Hospital in Boston found an elevated risk with semaglutide of a condition ...

As Phil Taylor reported, this morning, the Association of the British Pharmaceutical Industry (ABPI) released its comments on ...

This time last year, Pieris also lost a partnership with AstraZeneca on respiratory drug candidate elarekibep, one of up to ...

Boehringer filed its challenge last August after it became clear that its big-selling diabetes treatment Jardiance ...

Just like people, no two cancer cells are alike. And now, scientists from the University of Surrey and SCIEX have come ...

About Aktiia - A vehicle for discovery in blood pressure Aktiia was founded in Switzerland in May 2018 from a passion to ...

While the headlines are all about the Labour landslide in the UK general election this morning, Wes Streeting, who has been ...

NeuroSense said that ALSFRS-R is the current “gold-standard” scale used in ALS drug development and the new data highlights ...

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 ...

The Series B – led by Forbion and joined by other investors, including Syncona, Oxford Science Enterprises, and Oxford ...

The European Commission has become the first regulator worldwide to approve Sanofi and Regeneron’s IL-4 and IL-13 inhibitor ...

The UK move follows the publication of guidelines published by the International Society for Stem Cell Research (ISSCR) in ...